High materiality8/10
Bristol Myers price target raised to $75 from $72 at Guggenheim
Why it may matterVerify against the original reporting
buy
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
BMY received an analyst target update from Guggenheim.
- Guggenheim raises BMY target to $75 from $72.
Key facts
- 01
Target: $75
- 02
Posted price: $64.86
- 03
Analyst firm: Guggenheim
- 04
Analyst: Seamus Fernandez
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.